Exploring MMIHS vs Hirschsprung: Understanding Congenital Megacystis and Abdominal Distension in an Infant
**Patient Information** - **Age:** 13 months - **Gender:** Male - **Height:** 80 cm - **Weight:** 8.9 kg (notably lost 1.5 kg post-norovirus infection this month) - **Location:** Berlin, Germany **Current Medications:** - Prophylactic antibiotics since infancy - Laxbene **Medical Background:** The infant has been diagnosed with congenital megacystis and underwent surgery for posterior urethral valves (PUV). Urodynamic studies indicate a hypoactive bladder, and there is no evidence of vesicoureteral reflux. The bladder can hold approximately 300–320 ml but does not fully discharge; residual urine levels are between 20-100+ ml. The patient does not urinate during sleep and is currently catheterized 3 to 4 times a day. As for bowel health, a diagnosis has not yet been established. It appears that gas is becoming trapped in the upper abdomen, raising concerns about possible impaired intestinal motility. Recent imaging through MRI and CT scans revealed: - No indications of spinal or neurological issues - Dilated bowel loops The infant experienced a significant norovirus infection in January, necessitating a 14-day hospitalization. A motility disorder has been suspected since that time. Meconium was passed within the first 24 hours after birth, and constipation was observed starting at three months, characterized by hard, dry stools and straining. The infant was switched to a formula for cow's milk protein allergy (CMPA) combined with Laxbene. In the past three to four months, symptoms have intensified, causing: - Daily bloating leading to noticeable abdominal distension - Vomiting episodes when the abdomen becomes taut Occasionally, passing stool or gas will provide some relief, but this is not consistent. The distension tends to lessen overnight but reappears as the day progresses. **Inquiry Points:** 1. Which diagnostic evaluations should be conducted before we refer to a specialized motility clinic? 2. Is it advisable to proceed with a rectal biopsy now to exclude Hirschsprung disease? 3. For a referral in Germany, which specific specialty should we seek assistance from? Thank you for your help!
Answers (1)
2/13/2026, 2:40:46 PM
OpenHealth AI
Thank you for providing detailed information about the patient's condition, which helps clarify your concerns. Here are main points regarding your inquiries about further diagnostic evaluations, potential biopsy, and specialist referral.
Summary of Key Points
- Diagnostic Evaluations:
- Consider further imaging and gastrointestinal function tests.
- Rectal Biopsy:
- A rectal biopsy might be warranted to rule out Hirschsprung disease.
- Specialty Referral:
- A pediatric gastroenterologist specializing in motility disorders is recommended for further evaluation and management.
Detailed Explanation
-
Diagnostic Evaluations:
- Upper GI Series or Barium Swallow: This can help visualize the swallowing and potential obstruction issues.
- Gastrografin Enema: To assess for potential bowel obstructions or malformations.
- Anorectal Manometry: This test evaluates the function of the anal sphincter and rectal sensation, which is crucial for diagnosing motility disorders.
- 24-Hour pH Study: It can help gather more information regarding gastric reflux if vomiting persists.
- Assessing the current level of hydration and electrolyte balance is also critical given the recent vomiting and ileus-like symptoms.
-
Rectal Biopsy:
- Given the ongoing symptoms and suspicion of Hirschsprung disease, a rectal biopsy can provide valuable information. This test involves taking a small tissue sample from the rectum to assess for the presence or absence of ganglion cells. It is commonly done if constipation symptoms persist or worsen despite treatment.
-
Specialty Referral:
- Seek a pediatric gastroenterologist with experience in motility disorders for a thorough evaluation. It’s essential they have familiarity with congenital conditions and their associated complications. Additionally, this specialist can guide management strategies tailored for infants with complex cases like congenital megacystis and intestinal motility issues.
Next Steps
- Immediate Action:
- Schedule the recommended diagnostic evaluations as soon as possible, especially anorectal manometry and imaging studies.
- Review Symptoms:
- Keep a symptom diary noting episodes of vomiting, abdominal distension times, and any changes in bowel habits—this will assist the specialist.
- Prepare for Referral:
- Gather all previous medical records, imaging results, and treatment history to bring to the specialist visit.
Monitoring the infant's progression and symptoms will be vital in determining the urgency of further evaluations and interventions. Please ensure any emerging concerns, like significant vomiting or severe abdominal pain, are promptly addressed to rule out emergency issues. Let me know if you have further questions!
Related Questions
Struggling with Chronic Illness: A 21-Year-Old's Desperate Search for Answers
At just 21 years old, I find myself in a challenging predicament. Standing around 5'6" and weighing 102 pounds, I understand that I appear quite slender for my age, but I assure you, I do not have an eating disorder. I am reaching out in hopes of finding some clarity regarding my ongoing health issues. I frequently endure severe illness, experiencing relentless vomiting even on an empty stomach—my body somehow manages to expel its contents no matter what. Unfortunately, medication has been ineffective; I vomit even those pills, leaving me feeling hopeless. My body often prefaces these episodes with intense pain, particularly in my chest, and I frequently become lightheaded due to the discomfort. There have been instances where I fainted, prompting visits to the hospital. They performed scans on my stomach, which resulted in normal findings, but when I requested further examinations, the doctors refused, opting instead to prescribe medication that only exacerbated my symptoms. After stopping that treatment, I faced another emergency situation characterized by relentless vomiting, chest pain, and numbness. The medical team deemed it minor, advised against blood tests, and sent me home with prescriptions that I chose not to fill. My boyfriend suggested that I document my vomiting episodes by taking photos to illustrate the severity of my condition, but in those moments of distress, I'm too disoriented to consider reaching for a camera. I feel lost and overwhelmed as no solutions seem effective. This ongoing illness hampers my ability to work or engage in any physical or mental activities, forcing me to confront the reality that I’ve lost jobs due to these debilitating conditions. I'm at a loss—what steps should I take next?”
Back Pain and Numbness Post-Surgery
I am a 38-year-old woman, standing at 5'5" and weighing 125 pounds. Currently, my medication includes ibuprofen and gabapentin, and I do not consume alcohol or use illicit substances. In October, I underwent surgery due to a herniated disc and Cauda Equina syndrome. The neurosurgeon successfully decompressed my nerves, which was a positive outcome. However, I’ve been experiencing persistent pain and numbness, which my doctors have indicated is to be expected following such an injury due to possible nerve damage. Generally, I’ve been coping relatively well with these symptoms. Last week, I visited my doctor for a scheduled appointment regarding steroid injections. During the examination, he expressed the need for nerve testing prior to proceeding with any injections. I am entirely agreeable to this approach. However, I awoke the following morning to intensified pain. My primary concern centers around the severe back pain and increasing numbness that seems to be worsening. Prior to my last appointment, I could only detect numbness in my vaginal area when touched, but now it appears to be expanding from my labia towards my anal region, inner thighs, and buttocks. Additionally, I have lost sensation while urinating. I still feel the urge due to pressure in my bladder, but I no longer have the sensation of actually voiding. What began as minor numbness, primarily localized towards the right side, has progressed considerably over the past week. Is it possible to experience Cauda Equina syndrome again? Should I be concerned about these developments? I would prefer not to visit the emergency room unless absolutely necessary, as I do not want to misuse anyone's time if these symptoms are typical following my injury. Thank you for any guidance you can provide. I have uploaded the MRI results of my initial injury, as well as a follow-up MRI conducted in December; I'm uncertain if sharing them here is permissible.
Inquiry Regarding Vaccination and Health
Greetings! I am a 37-year-old woman who received a diagnosis of stage 3 breast cancer in the middle of 2024. Currently, I am undergoing treatment with Abemaciclib and Letrozole. I intended to pose a question to my oncologist during my last visit, but it slipped my mind. This isn't pressing, so I’m hoping to avoid reaching out to my oncology team unnecessarily. To provide some context, my blood cell levels have not returned to normal post-chemotherapy and remain somewhat on the lower side due to the effects of Abemaciclib. Just a couple of weeks ago, my absolute lymphocyte count was 0.7, and my absolute neutrophil count measured at 1.05. With travel plans in the near future, I've received the flu shot and am now considering additional vaccinations, such as a booster for COVID-19, pneumococcal vaccine, and hepatitis B. A blood test from my pregnancy indicated I no longer had immunity to hepatitis B, and I had intended to get vaccinated after giving birth, but then cancer intervened. My first question is: Given my low blood counts, do vaccines still provide any benefit? Would the advantages outweigh the costs and the discomfort of additional injections? I’ve endured quite a few needles, yet they still aren't my favorite thing. My second question is: After undergoing AC-T chemotherapy, am I still immune to the vaccines I received in my childhood? I’m particularly curious about whether I still have protection against measles, especially since I’m planning a trip to Disney. I appreciate any insights you can share! Thank you!
Mom's UTI: Improvement in Urine but Deterioration in Blood Tests After 5 Days of Antibiotic Treatment
**Patient Overview:** - Age: 56 years - Gender: Female - Height/Weight: 5 feet 6 inches, 71 kilograms - Ethnicity: Indian - Duration of Symptoms: Recurrent UTI for approximately 5 weeks - Location: India - Medical History: Prediabetes (HbA1c 5.8%), hypothyroidism, iron deficiency anemia - Current Medications: Nitrofurantoin 100 mg twice daily, Fosfomycin 3 g (completed), Metformin 500 mg twice daily, Thyroxine 62.5 mcg, iron supplements **Primary Concern:** My mother is currently facing a challenging recurrent urinary tract infection that has shown resistance to multiple antibiotics. Initially, she experienced a high fever (103°F) with her first infection in mid-January; however, she has not had a fever during subsequent occurrences, despite indicators suggesting the infection might be worsening. The confusion arises as her urine analysis appears to have improved while blood test results indicate a decline. **Timeline of Events:** **January 11, 2026:** - Diagnosis: E. coli UTI (100,000 CFU/mL) - Treatment initiated using antibiotics. - Symptoms recurred one week later with fever (103°F). **February 8, 2026 (New Infection):** - Urine culture revealed Citrobacter koseri (>100,000 CFU/mL) – indicating a different pathogen. - Urine pus cells: 60/HPF (elevated level). - Presence of blood in urine. - CRP level: 8.81 mg/L. - eGFR: 89 mL/min/1.73 m². **February 9, 2026:** - Medical advice included: - Nitrofurantoin 100 mg twice daily for 14 days. - Fosfomycin 3 g pouch for 3 days. - Clinical notes suggested possible pyelonephritis. - Blood Pressure: 146/80. **February 13, 2026 (Following 5 Days of Antibiotics):** - Urine examination showed positive trends: - Pus cells: Decreased to 6/HPF (from 60). - Bacteria: Not observed under microscopy. - Blood: Absent. - Leucocyte esterase: Still detectable. Despite improvements in urine analysis, blood results showed a concerning turn: - CRP: Increased to 17.47 mg/L (previously 8.81) - signifying a doubling of inflammation. - ESR: 60 mm/hr (normal range <30) - a new test result indicating inflammation. - eGFR: Dropped to 84 (from 89), suggesting declining kidney performance. - Hemoglobin: 11.4 g/dL (down from 11.9). - Sodium level: 134.6 (mildly decreased). **Key Questions:** 1. What could explain the significant reduction in urine pus cells (from 60 to 6) while the CRP levels have doubled (from 8.81 to 17.47)? Does this indicate a potential progression of the infection from the bladder to the kidneys? 2. Is the absence of fever a notable factor? With the first infection accompanied by a fever exceeding 103°F, her current lack of fever alongside rising blood markers is perplexing. Could her prediabetic state be concealing symptoms? 3. Are the prescribed antibiotics sufficient? While I acknowledge that Nitrofurantoin is effective in targeting the urinary tract, it may not adequately penetrate kidney tissues. Should alternative antibiotics be considered? 4. Does this clinical pattern suggest confirmed pyelonephritis? Considering: - Improvement in local urine parameters - Deterioration of systemic blood markers - Decreasing kidney function - Absence of fever amidst elevated CRP/ESR. 5. How immediate is the need for intervention? Should we consult the doctor without delay, or is it acceptable to wait until she completes the current antibiotic regimen? 6. Is hospitalization necessary? Given the concerning increase in CRP and declining renal function, would intravenous antibiotic treatment be warranted? **My Concerns:** Initially, the doctor raised the possibility of pyelonephritis, and the observed improvement in urine combined with the decline in blood tests seem to strengthen that suspicion. The absence of fever raises doubts about her true health status, especially with kidney function decreasing from 89 to 84 within just 5 days—this development is quite alarming. I appreciate any insights or advice on how to proceed further.
Should I Schedule a Follow-Up MRI or Delay?
Greetings! Recently, I underwent an abdominal MRI due to some concerns regarding my pancreas. Although the results indicated that my pancreas was clear, the scan did reveal two lesions on my liver, each under 5 cm, which the radiologist suggested might be adenomas. I'm reaching out with a concern: my physician has recommended another MRI using Eovist to create a baseline for ongoing observation of these lesions. However, I experienced some adverse effects after the previous MRI; while I didn’t have a direct allergic reaction, my body didn’t respond well overall, resulting in inflammation and discomfort in the upper abdominal region. Furthermore, I had a brain MRI conducted shortly before this for an unrelated matter. At the age of 35, I wonder about the necessity of this follow-up MRI. Is it wise to undergo yet another imaging procedure with contrast so soon, especially if I risk a heightened reaction? Or would it be acceptable to postpone this for a few months? Could the radiologist require this specific MRI for my liver to rule out any potential malignancy, especially in light of having not highlighted that risk in the previous report? I am prepared to proceed with the MRI if it’s crucial for cancer screening, but considering that these lesions will be closely monitored over time, is it essential to repeat the procedure at this prompt interval? As for the previous findings: - "Liver: A caudate lobe lesion measuring 2.7 cm shows faint hyperintensity on DWI, mild arterial enhancement, and no indications of washout. - There is also a smaller lesion of 1.4 cm at segment six displaying similar imaging characteristics." The impression noted: - “A 2.7 cm lesion in the caudate lobe and a 1.4 cm lesion in segment 6 show faint DWI hyperintensity and mild arterial hyperenhancement without washout. The imaging suggests these are likely benign adenomas, with focal nodular hyperplasia being a less probable consideration.”